Page 9 - These Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

4.2.3 Wellness Hurts 4.3 Instrumentation and Automation 4.3.2 The Shrinking Machine. 4.4 Diagnostic Technology Development 4.4.2 POCT/Self Testing as a Disruptive Force 4.4.3 The Genetics Play - One Test for All Known Infections 4.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics 5. Molecular Dx - Infectious Disease Recent Developments Recent Developments- Importance and How to Use This Section Importance of These Developments Fusion Genomics to Assess NGS-Based Respiratory Tract Infection Assay New Genomic Tests Diagnose Deadly Infections Faster Biotia Raises $2.4M Seed Round ...

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Impact of NGS on pricing 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Liquid Biopsy Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Liquid Biopsy NGS Panels - Diverse Test Claims CMS Colon Cancer Screening Memo Bodes Well for Assays Natera Liquid Biopsy Test Coverage to Expand Freenome Closes Financing to...

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic February 02, 2021 04:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.com's offering. The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitoring. The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Poten...

4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Qiagen Expands Immuno-Oncology Portfolio IncellDx Awarded PD-L1 Detection Patent FDA Approves CDx for Trastuzumab Promega Nabs CE Mark for Microsatellite Instability IVD ArcherDx partners with AstraZeneca for Immuno-Oncology Germline Results Guides Precision Therapy ...

Share this article Share this article ResearchAndMarkets.com's offering. Antimicrobial Resistance is creating new kinds of infections and "superbugs" that are resistant to current antibiotic medicines. New technologies (and new drugs) are under development to capture this growing market. We have identified the 6 Key Large Opportunities in this space and developed market forecasts.The publisher has looked at the technology picture too, giving you, plain language understanding of the different ways pathogens, and infections, can be treated, including an explanation of the key role diagnostics ...